Dr. Yom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th Street
Suite L1101
San Francisco, CA 94143Phone+1 415-353-7175Fax+1 415-353-9883
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2003 - 2007
- University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2002 - 2003
- Perelman School of Medicine at the University of PennsylvaniaClass of 2002
Certifications & Licensure
- CA State Medical License 2007 - 2026
- TX State Medical License 2007 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
- Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma Start of enrollment: 2013 May 01
- Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 124 citationsRandomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.K Kian Ang, Qiang Zhang, David I Rosenthal, Phuc Felix Nguyen-Tan, Eric J Sherman
Journal of Clinical Oncology. 2014-09-20 - 47 citationsUndifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomesDaniel S. Winchester, Julia S. Lehman, Tiffany L. Tello, Nicolette T. Chimato, Thomas L. Hocker
Journal of the American Academy of Dermatology. 2018-11-01 - 154 citationsThe International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in...Daniel Shao-Weng Tan, Sue S. Yom, Ming-Sound Tsao, Harvey I. Pass, Karen Kelly
Journal of Thoracic Oncology. 2016-07-01
Press Mentions
- Plenary Session SummaryOctober 8th, 2024
- Trial “Informs Practice Tremendously” for Low-Risk HPV-Oropharyngeal CancerOctober 8th, 2024
- De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal CancerOctober 2nd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: